<?xml version="1.0" encoding="UTF-8"?>
<p id="par0075">Overall, although our knowledge of the interplay between SARS-CoV-2 and the host immune system is still limited, we believe that IFN-I can represent not only a direct antiviral treatment restricting early viral spread, but also a valuable tool to enhance humoral and cellular immunity, thus halting viral infection from progressing towards a more severe form of disease.</p>
